Blood Work on Cycle: Which Markers to Monitor
Blood Work · 10 min read · Updated on May 23, 2026
Blood work on cycle is the single tool that turns a cycle from a subjective experiment into a monitored protocol. You do not feel a hematocrit at 56%, a crashed HDL, or an estradiol three times above target — not before something actually breaks. Every lucid evaluation of a cycle gets built on the labs, not on the mirror and not on the feel.
This guide is the head of the blood-work cluster. It lays out the full map: the six big panels worth watching on cycle, their key markers, their reference ranges, and the minimum schedule (baseline, mid-cycle, post-PCT). For the deep dive panel by panel, this page hands off to the supporting guides — hematocrit, cholesterol, liver health, hormonal markers, blood test schedule and heart health on cycle.
Why blood work is non-negotiable
The effects of a cycle are both external — what you see in the mirror, what the bar says — and internal, where the real story plays out. The vast majority of serious side effects from a cycle (very high hematocrit, prolonged hormonal suppression, hepatotoxicity, dyslipidemia, hypertension) are silent at the start. The moment they become symptomatic is precisely the moment they are already well established [2].
What blood work actually lets you do
- Build your personal baseline. Without reference values measured before the cycle, no mid-cycle reading can be interpreted. The 'lab range' is a population spread — not yours.
- Catch things early. A hematocrit going from 45% to 50% between baseline and week 6 is not alarming in absolute terms, but it signals a trajectory. At 53–54%, the warning threshold is crossed before any symptom [4].
- Dose less blind. Measuring estradiol avoids the classic mistake: bringing in an aromatase inhibitor preventively and crashing a hormone you actually need for well-being, lipids and libido.
- Validate recovery. The only way to confirm that your PCT worked is to measure LH, FSH and testosterone 4 to 6 weeks after the last SERM dose.
The six panels to watch on cycle
Cycle monitoring revolves around six big panels. Each covers a specific risk and has its dedicated guide in this cluster. The summary below gives the key markers and the consensus ranges, without replacing the detailed guides.
1. Complete blood count (CBC / hemogram)
This is the foundational blood panel. On cycle, the most watched marker here is hematocrit (Hct): the volume proportion of red blood cells in whole blood. Many steroids — notably boldenone and high-dose testosterone — drive erythropoiesis. Blood thickens; past a threshold, thrombotic risk climbs.
| Marker | Adult male reference | Warning threshold on cycle |
|---|---|---|
| Hematocrit | 40–50% | Monitor > 52%; act > 54% |
| Hemoglobin | 13–17 g/dL | Monitor > 17.5 g/dL |
| Red blood cells | 4.5–5.9 ×10⁶/µL | Notable upward trend |
| Platelets | 150–400 ×10³/µL | Monitor outside range |
Details — mechanism, management via blood donation, compound selection — in the hematocrit and steroids guide.
2. Lipid panel
Steroids — and especially 17-alpha-alkylated orals (Winstrol, Anavar, Anadrol) — wreck the lipid profile: HDL collapse, LDL rise. It is one of the most documented effects and one of the least felt subjectively [5].
| Marker | Adult male target | On cycle |
|---|---|---|
| HDL | > 40 mg/dL (1.0 mmol/L) | Frequent drop, especially under orals |
| LDL | < 130 mg/dL (3.4 mmol/L) | Frequent rise |
| Triglycerides | < 150 mg/dL (1.7 mmol/L) | Variable |
| Total cholesterol | < 200 mg/dL (5.2 mmol/L) | Often elevated |
Details and management levers (omega-3, cardio, compound selection) in cholesterol and lipid profile on cycle.
3. Liver panel
Priority monitoring if the cycle includes a hepatotoxic oral (Dianabol, Anadrol, Winstrol). Transaminases can climb notably [6]. The details (interpretation, role of training, TUDCA, NAC, maximum duration) are in the liver health on oral steroids guide.
| Marker | Adult reference | Note on cycle |
|---|---|---|
| AST (ASAT) | < 40 IU/L | A moderate rise can also come from recent heavy lifting |
| ALT (ALAT) | < 40 IU/L | More specific to the liver than AST |
| GGT | < 60 IU/L (male) | Sensitive marker of hepatic stress |
| Total bilirubin | < 1.2 mg/dL | Request when running orals |
4. Hormonal panel
On cycle, the hormonal panel captures HPTA suppression (LH, FSH bottomed out, endogenous testosterone collapsed — under exogenous testosterone, measured total testosterone is artificially high) and the estradiol level. Post-PCT, it is the panel that validates recovery.
| Marker | Adult male reference | Note |
|---|---|---|
| Total testosterone | 300–1000 ng/dL (10–35 nmol/L) | Artificially high on cycle |
| Free testosterone | 5–20 ng/dL | Reflects the bioactive fraction |
| LH | 1.5–9 IU/L | Crushed on cycle; recovery target post-PCT |
| FSH | 1.5–12 IU/L | Crushed on cycle |
| Estradiol (sensitive E2) | 10–40 pg/mL | Commonly cited target 20–40 pg/mL on cycle |
| SHBG | 10–60 nmol/L | Modulates free T; can drop under orals |
| Prolactin | < 15 ng/mL (male) | Request with nandrolone or trenbolone (progestins) |
Prolactin is specifically worth requesting under nandrolone or trenbolone, two progestogenic compounds that can drive it up.
Marker-by-marker interpretation, precise targets and how to read PCT bloods in the reading hormonal markers guide.
5. Kidney and thyroid panels (secondary)
Kidney function is less of a priority on a standard cycle, but useful in baseline and useful for users already on heavy supplementation (creatine, very high protein) or running an aggressive cycle. Thyroid function gets requested if the cycle includes a thyroid agent like T3.
| Marker | Adult reference | When to request |
|---|---|---|
| Creatinine | 0.7–1.3 mg/dL | Baseline + annual |
| BUN (urea) | 15–45 mg/dL | Baseline |
| eGFR | > 90 mL/min/1.73 m² | Key indicator of kidney function |
| TSH | 0.4–4.0 mIU/L | If T3/T4 used or symptoms |
| Free T3 | 2.0–4.4 pg/mL | If T3 used |
| Free T4 | 0.8–1.8 ng/dL | If thyroid treatment |
6. Blood pressure (home monitoring)
Not strictly a blood marker, but it belongs in cycle monitoring: many steroids — especially those that retain water or strongly stimulate erythropoiesis — push blood pressure up [7]. Regular home measurement is recommended (arm cuff, same conditions every time). Details in heart health on cycle.
The minimum schedule for a serious monitor
Blood monitoring of a cycle always follows three key moments [1]. The supporting guides — especially when to get bloods drawn — detail the variations depending on cycle length and compounds.
| Moment | Panels requested | Goal |
|---|---|---|
| Baseline (2 to 4 weeks before the first injection) | CBC, lipid panel, liver panel, full hormonal panel, creatinine, blood pressure | Personal reference values |
| Mid-cycle (week 4 to 8 depending on cycle length) | CBC (hematocrit +++), lipid panel, liver panel if orals, sensitive E2 | Catch the drift; adjust (blood donation, dose, AI if justified) |
| 4 to 6 weeks after the end of PCT | Full hormonal panel (LH, FSH, total and free testosterone, E2, SHBG, prolactin) | Validate HPTA recovery |
Reading a panel: the trap of the 'range'
Every lab report shows a reference range next to each value. That is useful, but it is also the first trap.
- The range is statistical, not individual. Testosterone at 320 ng/dL is 'within range' for an adult male; for a guy whose baseline was 750 ng/dL, that is a collapse.
- Units vary by country. Always note the unit: ng/dL vs nmol/L for testosterone, pg/mL vs pmol/L for estradiol. A unit error skews interpretation by a factor of 3 to 30.
- Assay methods differ. Sensitive estradiol (LC-MS/MS) vs standard immunoassay, free testosterone by dialysis vs calculated: these are not the same absolute values.
- Trend matters as much as value. A marker drifting from one panel to the next tells you more than an isolated reading. That is the whole point of keeping the history in one consistent format.
The useful reflex: compare each value to your previous personal panel, not to the mean of a population. AnaProtoKol's blood work feature is designed exactly for that — see the section below.
Centralize your panels: AnaProtoKol's dedicated feature
Blood monitoring of a cycle quickly produces a dozen PDF reports, with units and presentations that vary from lab to lab. Centralizing them in a spreadsheet is tedious and does not help you see the trend — which is the whole point.
What the blood work feature gives you
- 8 panels covering 59 markers. CBC, lipid, liver, hormonal (male and female), kidney, thyroid, glucose/diabetes, cardiovascular markers.
- PDF lab import. Lab reports (US labs like Quest and LabCorp, plus EU labs Cerba, Eurofins, Synlab, Biogroup and others) are recognized and the values pulled automatically.
- Graphical tracking over time. Each marker gets its own curve, with the baseline and reference thresholds rendered in the background.
- Comparison to your personal baseline. The dashboard highlights drift from your own baseline, not just from the lab range.
When a panel justifies a medical consult
A number of values or trends step outside the scope of self-monitoring. In those situations, a consult (primary care, endocrinologist, cardiologist depending on the marker) is not optional. Many users go through a TRT clinic that is willing to manage the bloods without questioning everything — that is one practical workaround in the US.
- Hematocrit ≥ 54% confirmed on two close measurements, especially with symptoms (headaches, blurred vision, dizziness).
- Transaminases (AST/ALT) > 3× the upper limit of the range under orals — immediate stop of the oral and consultation.
- Sustained systolic blood pressure > 140 mmHg, or symptoms (morning headaches, exertional shortness of breath).
- No hormonal recovery 8 weeks post-PCT (LH/FSH < 1 IU/L, persistent low testosterone).
- Any repeated out-of-range result you cannot explain, or any concerning clinical sign regardless of the numbers.
Frequently asked questions
How much does a full cycle blood panel cost in the US?
Through direct-to-consumer labs (Quest's QuestDirect, LabCorp's OnDemand, or specialist services like Marek Health and Discounted Labs), a full self-ordered cycle panel — CBC, comprehensive metabolic, lipid, full hormonal with sensitive E2 — typically lands in the $150 to $300 range without insurance. Going through a TRT clinic or your primary care with insurance can bring that down substantially. It stays a small share of the total cycle budget (compounds, PCT, gear): this is the least negotiable line item.
Can I order bloods without a doctor in the US?
Yes. Direct-to-consumer labs (QuestDirect, LabCorp OnDemand, Marek Health, Discounted Labs, Private MD Labs and similar) let you order panels without a doctor's prescription, paying out of pocket and skipping insurance entirely. Most US states allow this; a small number still require physician orders, which the platform usually arranges through a partnered physician. Without a prescribing doctor, no one interprets the results for you — the responsibility for reading the panel sits entirely on the user. That is why understanding the markers matters.
What time of day should I get my draw?
Morning, fasted, remains the gold standard for the majority of hormonal markers (testosterone, cortisol) — testosterone has a morning peak and an evening trough. For the lipid panel, a 10 to 12 hour fast gives the most reproducible numbers. For CBC and the liver panel, fasting is not strictly required but consistency from one draw to the next is: always draw under the same conditions and the trend reading becomes much cleaner.
Can the AnaProtoKol app read my lab PDFs?
PDF import from most US (Quest, LabCorp) and European labs is integrated into the blood work feature (8 panels, 59 markers). Values are recognized and placed on the tracking curves alongside the baseline and reference thresholds. Testing the import with your own PDFs is possible via the free 5-day trial (no card required).
Sources
Studies and scientific publications this guide relies on.
- Anawalt BD (2019). Diagnosis and Management of Anabolic Androgenic Steroid Use. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2018-01882
Revue clinique de référence sur l'évaluation et la prise en charge des utilisateurs de stéroïdes androgéniques : panels biologiques à doser (NFS, lipides, transaminases, testostérone totale et libre, LH, FSH, œstradiol, SHBG, prolactine), seuils d'alerte et conduite à tenir.
- Pope HG Jr, Wood RI, Rogol A, et al. (2014). Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine Reviews. doi: 10.1210/er.2013-1058
Énoncé scientifique de l'Endocrine Society : synthèse des effets indésirables des stéroïdes anabolisants sur les axes cardiovasculaire, hépatique, hormonal et psychiatrique, et plaidoyer pour une évaluation biologique systématique chez les utilisateurs.
- Bhasin S, Brito JP, Cunningham GR, et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2018-00229
Guideline 2018 de l'Endocrine Society sur la TRT chez l'homme hypogonadique : recommandations pour mesurer la testostérone totale à jeun le matin, suivre hématocrite et PSA, et utiliser le dosage d'œstradiol par LC-MS/MS chez l'homme.
- Calof OM, Singh AB, Lee ML, et al. (2005). Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. Journals of Gerontology Series A: Biological Sciences and Medical Sciences. doi: 10.1093/gerona/60.11.1451
Méta-analyse de 19 RCT (651 hommes traités vs 433 placebo) sur la TRT chez l'homme d'âge moyen et âgé : odds ratio d'érythrocytose (hématocrite > 50 %) multiplié par ~4 sous testostérone, sans excès d'événements cardiovasculaires significatif sur la durée des essais.
- Hartgens F, Kuipers H (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine. doi: 10.2165/00007256-200434080-00003
Revue systématique des effets cliniques et biologiques des AAS chez le sportif : effondrement du HDL et élévation du LDL particulièrement marqués sous oraux 17α-alkylés, élévation des transaminases, suppression de l'axe HPT.
- Bond P, Llewellyn W, Van Mol P (2016). Anabolic androgenic steroid-induced hepatotoxicity. Medical Hypotheses. doi: 10.1016/j.mehy.2016.06.004
Revue mécanistique : les stéroïdes 17α-alkylés survivent au premier passage hépatique en s'accumulant dans les hépatocytes — explication de l'élévation des transaminases et des atteintes cholestatiques observées sous oraux.
- Smit DL, Grefhorst A, Buijs MM, et al. (2022). Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse. Andrologia. doi: 10.1111/and.14372
Étude prospective HAARLEM (100 utilisateurs amateurs) documentant en parallèle l'élévation de la tension artérielle, la dégradation du profil lipidique et l'érythrocytose pendant le cycle, avec récupération partielle à 12 mois post-arrêt.
Guides liés
Track your cycle with real data
Daily journal, 52 compounds, blood work and AI analysis — to apply what you just read and track results cycle after cycle.
Free 5-day trial — no credit card